[HTML][HTML] Linezolid for treatment of chronic extensively drug-resistant tuberculosis
…, E Kang, B Jin, H Park, H Kwak, H Kim… - … England Journal of …, 2012 - Mass Medical Soc
Background Linezolid has antimycobacterial activity in vitro and is increasingly used for
patients with highly drug-resistant tuberculosis. Methods We enrolled 41 patients who had …
patients with highly drug-resistant tuberculosis. Methods We enrolled 41 patients who had …
Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea
CT Kim, TO Kim, HJ Shin, YC Ko… - European …, 2018 - Eur Respiratory Soc
Relatively little is known about the efficacy and safety of the programmatic use of bedaquiline
and delamanid in multidrug-resistant tuberculosis (MDR-TB) treatment. This study …
and delamanid in multidrug-resistant tuberculosis (MDR-TB) treatment. This study …
Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis
…, SJ Lee, LC Goldfeder, Y Cai, B Jin, Y Kim… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Pulmonary lesions from active tuberculosis patients are thought to contain persistent,
nonreplicating bacilli that arise from hypoxic stress. Metronidazole, approved for anaerobic …
nonreplicating bacilli that arise from hypoxic stress. Metronidazole, approved for anaerobic …
Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay …
…, EJ Cho, SS Roh, LE Smith, J Lee, CT Kim… - Journal of clinical …, 2015 - Am Soc Microbiol
Resistance to amikacin (AMK) and kanamycin (KAN) in clinical Mycobacterium tuberculosis
strains is largely determined by specific mutations in the rrs gene and eis gene promoter. We …
strains is largely determined by specific mutations in the rrs gene and eis gene promoter. We …
Geographic Differences in the Contribution of ubiA Mutations to High-Level Ethambutol Resistance in Mycobacterium tuberculosis
…, EJ Cho, JI Lee, SN Cho, CT Kim… - Antimicrobial agents …, 2016 - Am Soc Microbiol
Ethambutol (EMB) resistance can evolve through a multistep process, and mutations in the
ubiA (Rv3806c) gene appear to be responsible for high-level EMB resistance in …
ubiA (Rv3806c) gene appear to be responsible for high-level EMB resistance in …
A General Approach to Preferential Formation of Active Fe–Nx Sites in Fe–N/C Electrocatalysts for Efficient Oxygen Reduction Reaction
Iron–nitrogen on carbon (Fe–N/C) catalysts have emerged as promising nonprecious metal
catalysts (NPMCs) for oxygen reduction reaction (ORR) in energy conversion and storage …
catalysts (NPMCs) for oxygen reduction reaction (ORR) in energy conversion and storage …
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
…, TI Kim, SM Jeon, SP Hong, JH Cheon… - … journal of cancer, 2012 - Wiley Online Library
Metformin use has been associated with decreased cancer risk and mortality. However, the
effects of metformin on clinical outcomes of colorectal cancer (CRC) are not defined. This …
effects of metformin on clinical outcomes of colorectal cancer (CRC) are not defined. This …
Nanoporous metal oxides with tunable and nanocrystalline frameworks via conversion of metal–organic frameworks
TK Kim, KJ Lee, JY Cheon, JH Lee… - Journal of the …, 2013 - ACS Publications
Nanoporous metal oxide materials are ubiquitous in the material sciences because of their
numerous potential applications in various areas, including adsorption, catalysis, energy …
numerous potential applications in various areas, including adsorption, catalysis, energy …
[HTML][HTML] Kaempferol induces autophagic cell death via IRE1-JNK-CHOP pathway and inhibition of G9a in gastric cancer cells
Kaempferol, a flavonoid, found in traditional medicine, fruits, and vegetables, and an HDAC
inhibitor, is a powerful anti-cancer reagent against various cancer cell lines. However, …
inhibitor, is a powerful anti-cancer reagent against various cancer cell lines. However, …
Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy
Background & Aims Recently, the PAGE-B score and Toronto HCC risk index (THRI) have
been developed to predict the risk of hepatocellular carcinoma (HCC) in Caucasian patients …
been developed to predict the risk of hepatocellular carcinoma (HCC) in Caucasian patients …